Octreotide Acetate Depot Powder AND Solvent Suspension Injection 10 MG 20 MG AND 30 MG Product Specific Bioequivalence Guidance
TGA (CWLTH) resource. Rules Mate indexes this as part of the Australian compliance corpus. Click through for the regulator's primary source.
https://www.tga.gov.au/resources/resources/international-scientific-guidelines-adopted-australia/octreotide-acetate-depot-powder-and-solvent-suspension-injection-10-mg-20-mg-and-30-mg-product-specific-bioequivalence-guidance
Rules Mate indexes Australian government compliance resources to make them searchable. We link to + summarise; always verify the live source before acting.